ArticleFrontiers in oncology2024

Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma.

Cora Hedrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.